We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App




Real-Time PCR Kit Enables Specific Identification and Differentiation of Rhinovirus and/or Enterovirus

By LabMedica International staff writers
Posted on 21 Jul 2023

Echovirus 11 (E-11), part of the Enterovirus genus, is associated with a variety of health conditions, from mild non-specific symptoms to severe systemic and neurological disorders like skin rashes, fever, meningitis, encephalitis, and acute flaccid paralysis (AFP). More...

It poses a significant threat to neonates and infants, leading to high rates of illness and death. E-11 can be transmitted from mother to child, making infection control a challenge. In neonates, these infections can cause severe inflammatory diseases, including acute hepatitis with coagulopathy.

Without a global enterovirus surveillance program, estimating the current prevalence of severe neonatal E-11 infections or the virus's circulation rate in the population is difficult. Only the most severe cases are likely to be detected through active sample testing and typing efforts without enterovirus surveillance. Furthermore, there may be unreported and undiagnosed cases of severe neonatal enterovirus infection since non-polio enterovirus infection is often not a reportable disease. Now, a real-time PCR test can quickly and accurately identify as well as differentiate Rhinovirus and/or Enterovirus, allowing for personalized treatment and proper medical care.

CerTest Biotec’s (Zaragoza, Spain) VIASURE Rhinovirus + Enterovirus real-time PCR kit is specifically designed for the identification and differentiation of Rhinovirus and/or Enterovirus. The primer/probe design enables the detection of Enterovirus (Echovirus-11 (E-11)), facilitating early and precise diagnosis of this viral infection. The qPCR (real-time PCR) method is highly sensitive and specific, delivering reliable and accurate results quickly. The VIASURE kit offers considerable benefits in diagnosing Rhinovirus and Enterovirus infections. By specifically detecting Echovirus-11, it aids in distinguishing it from other Enterovirus family members, ensuring a more comprehensive and accurate infection assessment.

Early detection of Echovirus-11 is vital for appropriate and timely clinical management of affected patients. This includes identifying outbreaks, isolating and treating affected cases adequately, and monitoring the virus spread to implement effective control and preventive measures. Moreover, the test’s ability to differentiate between Rhinovirus and Enterovirus is invaluable as these two virus families can present similar symptoms, but their clinical implications and treatments could vary. Accurate diagnosis allows for more personalized and appropriate patient care. The VIASURE Rhinovirus + Enterovirus real-time PCR kit serves as a crucial tool for rapid and precise viral infection diagnosis, especially in Echovirus-11 cases, significantly contributing to efficient public health and healthcare management.

Related Links:
CerTest Biotec


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical Abstract (Ziegler, AG., Rewers, M.J., Achenbach, P. et al. Diabetologia (2026). https://doi.org/10.1007/s00125-026-06841-z)

International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures

Hospitals face persistent pressure to improve diagnostic accuracy while reducing unnecessary testing and costs. Misordered or overused assays can complicate infection metrics, trigger penalties, and strain... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.